# Study Evaluating Dexmedetomidine in the Acute Treatment of Electrical Storm

Study · id `cardio:ct-nct06281977` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06281977](<https://clinicaltrials.gov/study/NCT06281977>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06281977

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 192 participants.

## Technical summary

Registry record NCT06281977. Randomized; triple masking; primary purpose treatment. Start 2024-05-08 (actual); primary completion 2027-05-08 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 192 participants (planned count; ClinicalTrials.gov record NCT06281977, source copy `cardio:ctgov-nct06281977-2026-07-07`, retrieved 2026-10-26)
- Started: 2024-05-08 (actual) (ClinicalTrials.gov record NCT06281977, source copy `cardio:ctgov-nct06281977-2026-07-07`, retrieved 2026-10-26)
- Primary completion: 2027-05-08 (anticipated) (ClinicalTrials.gov record NCT06281977, source copy `cardio:ctgov-nct06281977-2026-07-07`, retrieved 2026-10-26)
- Completion: 2027-08-01 (anticipated) (ClinicalTrials.gov record NCT06281977, source copy `cardio:ctgov-nct06281977-2026-07-07`, retrieved 2026-10-26)
- Countries: United States; Canada (ClinicalTrials.gov record NCT06281977, source copy `cardio:ctgov-nct06281977-2026-07-07`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06281977-2026-07-07`, retrieved 2026-10-26)

## The registry's words

- Brief title: Study Evaluating Dexmedetomidine in the Acute Treatment of Electrical Storm
- Acronym: SEDATE
- Condition: Ventricular Tachycardia
- Condition: Ventricular Arrhythmias
- Condition: Ventricular Fibrillation
- Condition: Recurrent Ventricular Tachycardia
- Intervention (Drug): Dexmedetomidine
- Intervention (Drug): Normal saline
- Lead sponsor: Ottawa Heart Institute Research Corporation
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Ventricular tachycardia (`cardio:ventricular-tachycardia`)
- Registry lists this organization as the lead sponsor: Ottawa Heart Institute Research Corporation (`cardio:org-ottawa-heart-institute-research-corporation`)

## Provenance

Content hash: 1c49eccbc702f37c973dae44dd83c6244d69894f4224c4627d9ae045e419c03e
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
